Valneva SE (VALN) Financials
VALN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 551.1 million | 384.3 million |
2023-06-30 | 590.0 million | 382.6 million |
2023-03-31 | 643.1 million | 419.9 million |
2022-12-31 | 666.8 million | 430.9 million |
VALN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -76.9 million | ? |
2023-06-30 | -48.4 million | ? |
2023-03-31 | -30.7 million | ? |
2022-12-31 | -67.2 million | ? |
VALN Net Income
No data available :(
VALN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 181.3 million | - | 56.8 million |
2023-06-30 | 222.3 million | - | 58.5 million |
2023-03-31 | - | - | 60.3 million |
2022-12-31 | 310.6 million | - | 57.5 million |
VALN Shares Outstanding
VALN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 1.3 million | 17.2 million | 12.9 million | 14.7 million |
2023-06-30 | 3.7 million | 13.0 million | 14.0 million | 12.0 million |
2023-03-31 | 4.2 million | 15.3 million | 10.9 million | 9.8 million |
2022-12-31 | 7.3 million | 31.7 million | 11.6 million | 11.2 million |
VALN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 40.3 million | 22.2 million |
2023-06-30 | 43.7 million | 36.3 million |
2023-03-31 | 36.5 million | 22.3 million |
2022-12-31 | 119.6 million | 130.6 million |
VALN
Price: $7.57
52 week price:
Earnings Per Share: -1.58 USD
P/E Ratio: -4.83
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 8187
Market Capitalization: 571.8 million